5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Exposing synonymous mutations.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Synonymous codon changes, which do not alter protein sequence, were previously thought to have no functional consequence. Although this concept has been overturned in recent years, there is no unique mechanism by which these changes exert biological effects. A large repertoire of both experimental and bioinformatic methods has been developed to understand the effects of synonymous variants. Results from this body of work have provided global insights into how biological systems exploit the degeneracy of the genetic code to control gene expression, protein folding efficiency, and the coordinated expression of functionally related gene families. Although it is now clear that synonymous variants are important in a variety of contexts, from human disease to the safety and efficacy of therapeutic proteins, there is no clear consensus on the approaches to identify and validate these changes. Here, we review the diverse methods to understand the effects of synonymous mutations.

          Related collections

          Author and article information

          Journal
          Trends Genet
          Trends in genetics : TIG
          Elsevier BV
          0168-9525
          0168-9525
          Jul 2014
          : 30
          : 7
          Affiliations
          [1 ] Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. Electronic address: ryan.hunt@fda.hhs.gov.
          [2 ] Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA.
          [3 ] Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. Electronic address: zuben.sauna@fda.hhs.gov.
          [4 ] Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA. Electronic address: chava.kimchi-sarfaty@fda.hhs.gov.
          Article
          S0168-9525(14)00068-7
          10.1016/j.tig.2014.04.006
          24954581
          539bb89e-2780-45aa-b0b0-a13f03fb69e6
          Published by Elsevier Ltd.
          History

          codon usage,mRNA structure,synonymous mutation,synonymous single nucleotide polymorphism,translation speed

          Comments

          Comment on this article